Recently, Huakang Clean announced that, as the lead party of a consortium, it has successfully won a bid for a large-scale cleanroom engineering project valued at RMB 157 million. The project primarily involves the construction of high-standard cleanrooms for the biopharmaceutical sector, covering the full scope of services including design, construction, and system integration. As a leading player in China’s cleanroom engineering industry, Huakang Clean has earned strong client recognition thanks to its technical expertise in GMP compliance, air cleanliness control, and project management. This win not only highlights the company’s comprehensive competitiveness in infrastructure projects for high-end manufacturing and life sciences but also provides solid support for its future revenue growth. Industry analysts note that with China’s continued investment in strategic emerging sectors such as biopharma and semiconductors, demand for cleanroom engineering is expected to grow steadily, positioning Huakang Clean to further strengthen its market position through accumulated technical know-how and project experience.The consortium-based collaboration model also underscores the company’s strengths in resource integration and coordination, enhancing both execution efficiency and delivery quality. Looking ahead, Huakang Clean stated it will continue focusing on high-barrier, high-value-added segments within cleanroom engineering to drive high-quality business development.
近日，华康洁净发布公告称，公司作为联合体牵头方，成功中标某大型洁净室工程项目，中标金额达1.57亿元人民币。该项目主要涉及生物医药领域的高标准洁净厂房建设，涵盖设计、施工及系统集成等全流程服务。作为国内洁净室工程领域的领先企业，华康洁净凭借其在GMP合规、空气洁净控制及项目管理方面的技术优势，赢得了客户的高度认可。此次中标不仅体现了公司在高端制造和生命科学基础设施建设中的综合竞争力，也为其未来业绩增长提供了有力支撑。业内分析指出，随着国家对生物医药、半导体等战略性新兴产业的持续投入，洁净室工程市场需求将持续扩大，华康洁净有望凭借技术积累与项目经验进一步巩固市场地位。此次联合体合作模式也凸显了公司在资源整合与协同能力方面的优势，有助于提升项目执行效率与交付质量。未来，华康洁净表示将继续聚焦高技术壁垒、高附加值的洁净工程领域，推动企业高质量发展。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/8814.html